Internal Medicine, Rheumatology · Seattle, WA
NPI
1013116722
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
201 16th Ave E
Seattle, WA, 98112
Phone (206) 326-3000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$652K
2,398 prescriptions
Company payments, 2025
$0
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Michael D Cho prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 499 prescriptions and refills. In total Michael D Cho wrote 2,398 Medicare prescriptions that cost $652K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-31.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 499 | 1,157 | 161 | $9,909 |
| Hydroxychloroquine Sulfate Generic | 341 | 940 | 121 | $16K |
| Prednisone Generic | 327 | 445 | 137 | $3,098 |
| Sulfasalazine Dr Sulfasalazine | 203 | 365 | 67 | $12K |
| Allopurinol Generic | 197 | 519 | 53 | $2,621 |
| Pantoprazole Sodium Generic | 133 | 387 | 57 | $2,085 |
| Colchicine Generic | 97 | 178 | 43 | $3,068 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 59 | 63 | Under 11 | $61K |
| Amjevita(Cf) Adalimumab-Atto | 47 | 47 | Under 11 | $40K |
| Sulfasalazine Generic | 44 | 130 | 15 | $3,409 |
| Leflunomide Generic | 41 | 103 | 13 | $1,055 |
| Omeprazole Generic | 40 | 109 | 14 | $445 |
| Xeljanz Tofacitinib Citrate | 35 | 35 | Under 11 | $88K |
| Enbrel Sureclick Etanercept | 28 | 28 | Under 11 | $137K |
| Enbrel Etanercept | 23 | 24 | Under 11 | $107K |
Brand drugs: 517 claims; generic drugs: 1,859 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael D Cho $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.